obesity drug news today glp-1 september 2025 Weight-Loss Demonstration Begins July 2026 Trump calls out weight-loss drugs

Rather than directly activating GABA-A receptors, the peptide appears to maintain homeostasis of the entire GABA receptor complex, preventing the desensitization and compensatory changes that produce tolerance and dependence

[PubMed] [Google Scholar] 75.Lojo N., Rasic Z., Sever A.Z., Kolenc D., Vukusic D., Drmic D., Zoricic I., Sever M., Seiwerth S., Sikiric P

Both remain in committee as of early 2026

Next step If the topic still fits your goal after reading, the get-started flow should collect the clinical context needed for provider review

GLP-1 microdosing uses sub-therapeutic doses (0.05-0.25mg semaglutide weekly vs standard 0.25-2.4mg) to minimize gastrointestinal side effects while achieving mild appetite suppression

Within 6 weeks everything went into the normal range